HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Mechanism of action and persistence of neuroprotection by cell-permeant Ca2+ chelators.

Abstract
Cell-permeant Ca2+ chelators such as 1,2-bis-(2-aminophenoxy)ethane- N,N,N',N'-tetraacetic acid acetoxymethyl ester (BAPTA-AM) have been reported to protect neurons in experimental focal cerebral ischemia. However, their in vivo actions are uncertain, and their protective efficacy is proven only in brief cerebral ischemia paradigms. Here we examine their mechanism of action in vitro and duration of efficacy in vivo. Electrophysiological studies were made in CA1 neurons in rat hippocampal slices. When superfused with BAPTA-AM (30-50 microM), CA1 somatic field potential recordings showed attenuation of the population spike amplitude, and intracellular recordings showed reduced excitatory postsynaptic potentials, indicating inhibition of excitatory synaptic transmission. Also, Ca(2+)-dependent accommodation and post-spike-train hyperpolarizations were reduced, indicating Ca2+ chelation hear the internal cell membrane surface. To determine whether Ca2+ chelators reduce the size of cerebral infarction rather than simply delaying its evolution, we studied the effects of BAPTA-AM treatment on infarction size 24 h after permanent middle cerebral artery occlusion. Fischer rats (n = 8 per group) were pretreated with saline, BAPTA-AM (20 mg/kg), or MK-801 (0.5 mg/kg). Infarction volumes in animals treated with BAPTA-AM were reduced by 50.5% compared with controls (p = 0.018), whereas animals treated with MK-801 experienced a statistically insignificant infarct volume reduction (26%; p = 0.27). These data show a persistence of neuroprotection by the Ca2+ chelator at 24 h and indicate that it may act by attenuating synaptic transmission and subplasma membrane Ca2+ excess.
AuthorsM Tymianski, I Spigelman, L Zhang, P L Carlen, C H Tator, M P Charlton, M C Wallace
JournalJournal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism (J Cereb Blood Flow Metab) Vol. 14 Issue 6 Pg. 911-23 (Nov 1994) ISSN: 0271-678X [Print] United States
PMID7929656 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't, Review)
Chemical References
  • Chelating Agents
  • Neuroprotective Agents
  • 1,2-bis(2-aminophenoxy)ethane N,N,N',N'-tetraacetic acid acetoxymethyl ester
  • Egtazic Acid
  • Dizocilpine Maleate
  • Calcium
Topics
  • Animals
  • Brain (drug effects, pathology, physiopathology)
  • Brain Ischemia (physiopathology)
  • Calcium
  • Cell Membrane Permeability
  • Cerebral Infarction (pathology)
  • Chelating Agents (pharmacokinetics, pharmacology)
  • Dizocilpine Maleate (pharmacology)
  • Egtazic Acid (analogs & derivatives, pharmacology)
  • Electrophysiology
  • In Vitro Techniques
  • Male
  • Neurons (drug effects, physiology)
  • Neuroprotective Agents (pharmacology)
  • Rats
  • Rats, Wistar
  • Synaptic Transmission (drug effects)
  • Time Factors

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: